- Home
- APGE vs UE Comparison
APGE vs UE Comparison
Compare APGE & UE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- UE
- Stock Information
- Founded
- APGE 2022
- UE 2014
- Country
- APGE United States
- UE United States
- Employees
- APGE N/A
- UE N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- UE Real Estate
- Sector
- APGE Health Care
- UE Finance
- Exchange
- APGE Nasdaq
- UE Nasdaq
- Market Cap
- APGE 2.3B
- UE 2.6B
- IPO Year
- APGE 2023
- UE N/A
- Fundamental
- Price
- APGE $34.55
- UE $20.04
- Analyst Decision
- APGE Strong Buy
- UE Hold
- Analyst Count
- APGE 5
- UE 1
- Target Price
- APGE $83.50
- UE $22.00
- AVG Volume (30 Days)
- APGE 514.4K
- UE 770.2K
- Earning Date
- APGE 03-04-2025
- UE 02-12-2025
- Dividend Yield
- APGE N/A
- UE 3.79%
- EPS Growth
- APGE N/A
- UE N/A
- EPS
- APGE N/A
- UE 0.60
- Revenue
- APGE N/A
- UE $444,966,000.00
- Revenue This Year
- APGE N/A
- UE N/A
- Revenue Next Year
- APGE N/A
- UE $1.37
- P/E Ratio
- APGE N/A
- UE $33.55
- Revenue Growth
- APGE N/A
- UE 9.35
- 52 Week Low
- APGE $32.46
- UE $15.81
- 52 Week High
- APGE $72.29
- UE $23.85
- Technical
- Relative Strength Index (RSI)
- APGE 35.39
- UE 42.53
- Support Level
- APGE $32.46
- UE $19.71
- Resistance Level
- APGE $37.42
- UE $21.73
- Average True Range (ATR)
- APGE 2.17
- UE 0.57
- MACD
- APGE -0.30
- UE -0.02
- Stochastic Oscillator
- APGE 20.84
- UE 16.34
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
About UE Urban Edge Properties of Beneficial Interest
Urban Edge Properties is a real estate investment trust principally focused on the management and development of retail real estate properties in urban communities in the U.S. Having originally been created to hold the majority of Vornado Realty Trust's shopping center businesses, Urban Edge's asset portfolio is mostly composed of shopping centers and malls in terms of total square footage. The company's holdings include necessity and convenience-oriented retailers, such as department stores, grocers, health clubs, and restaurants. Urban Edge's properties are mainly located in the New York City metropolitan region and within the DC to Boston corridor. The company generates nearly all of its revenue through the collection of rent from a large number of tenants.